RKLB Maintained at Buy by Cowen & Co., May 2026

Cowen & Co. maintained its Buy rating on Rocket Lab USA (RKLB) on May 8, 2026, signaling continued confidence in the aerospace company. The analyst firm raised its price target to $120 from $90, reflecting a 33% upside from current levels. This Rocket Lab rating maintained action comes as the stock trades at $105.47, up 34% year-to-date. The aerospace and defense company operates in a high-growth sector with expanding launch services and satellite platform capabilities. Meyka AI rates RKLB with a grade of B, suggesting a hold position for investors.

Cowen Maintains Buy with Aggressive Price Target Hike

Price Target Raised 33% to $120

Cowen & Co. raised its price target to $120 from $90, representing significant upside potential. The new target implies 13.8% gains from the current $105.47 price level. This Rocket Lab rating maintained decision reflects analyst confidence in the company’s long-term growth trajectory. The aerospace firm’s expanding launch cadence and satellite platform revenue streams support the bullish outlook. Cowen’s maintained Buy rating aligns with 18 other analysts holding Buy ratings versus only 4 Hold ratings.

Market Performance and Momentum

Rocket Lab stock has surged 34.2% in the past day and 356.9% over the past year. The company’s market cap stands at $60.8 billion, making it a significant player in commercial spaceflight. Trading volume reached 79 million shares, 3.6 times the average daily volume. The stock trades near its 52-week high of $105.56, indicating strong investor appetite. This momentum supports the Rocket Lab rating maintained thesis from Cowen analysts.

Financial Metrics and Valuation Challenges

Revenue Growth Offset by Profitability Headwinds

Rocket Lab generated $1.12 in revenue per share trailing twelve months, with 38% annual revenue growth. However, the company posted negative earnings of $0.32 per share, reflecting heavy investment in R&D and manufacturing. Operating margins remain deeply negative at negative 33.2%, typical for growth-stage aerospace firms. The company’s R&D spending reached 43.6% of revenue, supporting development of the Neutron launch vehicle. Despite profitability challenges, gross margins improved to 36.6%, showing operational leverage potential.

Valuation Metrics and Cash Position

Rocket Lab trades at a steep 87.1x price-to-sales ratio, reflecting growth expectations. The price-to-book ratio stands at 27.5x, indicating premium valuation. The company maintains a strong cash position of $2.28 per share and a current ratio of 4.47x. Debt-to-equity remains minimal at 6%, providing financial flexibility. These metrics support why analysts maintain bullish stances despite near-term profitability challenges.

Analyst Consensus and Industry Position

Broad Buy Consensus Among Analysts

Eighteen analysts rate Rocket Lab as Buy, while only four maintain Hold ratings. No analysts rate the stock as Sell or Strong Sell, showing unanimous optimism. The consensus rating of 3.0 reflects strong bullish sentiment across the investment community. This Rocket Lab rating maintained action by Cowen aligns with the broader analyst consensus. The aerospace and defense sector benefits from government spending and commercial satellite demand tailwinds.

Meyka AI Grade and Forecast Outlook

Meyka AI rates RKLB with a grade of B, suggesting a hold position. This grade factors in S&P 500 benchmark comparison, sector performance, financial growth, key metrics, and analyst consensus. Meyka’s AI-powered market analysis platform forecasts yearly price targets of $112.01, with five-year projections reaching $291.61. The RKLB stock page provides real-time analyst coverage tracking and proprietary price forecasts. These grades are not guaranteed and we are not financial advisors.

Growth Catalysts and Strategic Initiatives

Neutron Launch Vehicle Development

Rocket Lab is developing the Neutron 8-ton payload class launch vehicle, targeting the medium-lift market. This vehicle addresses a significant gap between small and heavy-lift options. The Neutron program represents the company’s largest growth opportunity, with potential to triple addressable market. Development spending reflects management’s commitment to capturing this opportunity. Successful Neutron deployment could transform Rocket Lab’s profitability profile.

Photon Satellite Platform Expansion

The Photon satellite platform family generates recurring revenue from constellation management services. The company designs and manufactures spacecraft components for merchant customers. This business line provides higher-margin revenue compared to launch services. Expanding Photon adoption among commercial and government customers supports revenue diversification. The Rocket Lab rating maintained reflects confidence in these platform expansion opportunities.

Final Thoughts

Cowen & Co.’s maintained Buy rating and 33% price target increase to $120 underscore analyst confidence in Rocket Lab’s long-term potential. The aerospace company benefits from strong market tailwinds in commercial spaceflight and satellite services. While profitability remains elusive, revenue growth of 38% and gross margin expansion demonstrate operational progress. The Rocket Lab rating maintained decision reflects the company’s strategic positioning in high-growth markets. Meyka AI’s B grade suggests holding positions while monitoring execution on Neutron development and Photon platform adoption. Investors should weigh the premium valuation against long-term growth prospects in the expanding space economy.

FAQs

Disclaimer:

Stock markets involve risks. This content is for informational purposes only. Analyst ratings are opinions and not guarantees of future performance. Past performance does not guarantee future results. Meyka AI PTY LTD provides market analysis and data insights, not financial advice. Always conduct your own research and consider consulting a licensed financial advisor.